FDA Approves Biogen's AMEVIVE(R) (alefacept) for Treatment of Psoriasis
AMEVIVE is the first biologic treatment approved for psoriasis
AMEVIVE is the first biologic treatment approved for psoriasis
CLINICAL STUDY RESULTS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE SHOW PROMISING DATA ON ANTEGREN-® (natalizumab) IN THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS